| Code | CSB-BP5806MOV |
| Abbreviation | Recombinant Cynomolgus monkey ACVRL1 protein, partial (Active) |
| MSDS | |
| Size | $472 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
ACVRL1, a type I receptor in the TGF-β superfamily, plays a critical role in angiogenesis and vascular remodeling, making it a target of interest in cancer research where aberrant signaling contributes to tumor vasculature development. This partial extracellular domain construct spanning residues 22–118 demonstrates quantifiable antibody-binding activity in functional ELISA, with an EC50 of 6.893–8.194 ng/mL when immobilized at 2 μg/mL and challenged with anti-ACVRL1 recombinant antibody, confirming proper epitope presentation. The validated binding kinetics support use in therapeutic antibody epitope mapping, competitive inhibition screening to identify blocking candidates, and ligand-receptor interaction assays including ELISA and surface plasmon resonance. Produced in baculovirus with greater than 95% purity and endotoxin levels below 1.0 EU/μg, this protein meets the quality thresholds commonly required for antibody development workflows and provides a suitable positive control for binding assays targeting the ACVRL1 extracellular region.
There are currently no reviews for this product.